DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
— - 1 ’ - 1 Kleiner Perkins - 1 Andreessen Horowitz - 1 Suki - 1 Punit Soni - 1 Shiv Rao - 1 ” - 1
Top related locs:
Owkin
Top related orgs:
Business - 2 Cathay Innovation - 2 Service - 1 Healthcare - 1 Fund - 1 Optum Ventures - 1 Medical - 1 Microsoft - 1

Search resuls for: "Cathay Innovation"


3 mentions found


☆ VCs are clamoring to back 'screaming hot' startups using AI for medical records
  + stars: | 2024-02-21 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +7 min
Another AI medical records startup, DeepScribe, raised a $30 million Series A round in January 2022. AbridgeThe investor descent on medical-scribe startups reflects a blatant potential of automation tech to alleviate healthcare’s most critical issues. “This market is screaming hot,” said Bryan Roberts, a partner at Venrock and an investor in medical-scribe startup Suki. AdvertisementStill, as health systems increasingly adopt AI solutions to manage labor costs, these startups have room to grow into their valuations. Medical-scribe startups vying for the remaining slice of the pie are “in a pitch to the death,” Roberts said.
Persons: —, ’, Kleiner Perkins, Andreessen Horowitz, Suki, Punit Soni, Shiv Rao, ”, Bryan Roberts, ” Roberts, Annie Case, Case, Hermann, Keith Srakocic, Roberts, there’s, “ Organizations: Service, Business, Healthcare, Fund, Optum Ventures, Medical, Cathay Innovation, Microsoft, University of Pittsburgh Medical Center, University of Kansas Health, AP
☆ This AI startup founded by ex-Googlers just raised $35 million. Check out the 12-slide pitch deck Bioptimus used to land the funds.
  + stars: | 2024-02-20 | by ( Callum Burroughs | ) www.businessinsider.com   time to read: +2 min
Bioptimus, a new French AI startup for life sciences, has raised $35 million in seed funding. Founded in 2023, Bioptimus is the brainchild of Jean-Philippe Vert, a former research scientist at Google and recently chief R&D officer at French health AI startup Owkin. The company was formed to capitalize on the enormous potential of AI in biological sciences, Vert told Business Insider. "There is something very special now about AI," Vert said. Owkin, Vert's former employer, is an investor and partner to the startup, as is tech entrepreneur and investor Xavier Niel.
Persons: Bioptimus, Jean, Philippe Vert, Rolophe Jenatton, Xavier Niel Organizations: Google, Business, Sofinnova Partners, Cathay Innovation, Harvest, Fundraising Locations: Owkin
☆ See the 16-slide presentation a startup used to sell investors on a new approach to solving a $50 billion problem for Big Pharma
  + stars: | 2023-04-12 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +3 min
Inato, which matches pharma companies with hospitals for clinical trials, just landed $20 million. Three months after raising $14 million in Series A funding in February 2020, Inato's founders realized they were making the wrong product. The Paris-based startup was founded in 2016 to help pharmaceutical companies find the right sites to conduct their clinical trials. Now, pharma companies post their clinical trials onto Inato's platform, and sites can apply for the trials they're interested in. Inato provided Insider with the pitch deck it used to raise $20 million in Series A-2 funding.
0 next >>
Total: 3